$YTENQ
YIELD10 BIOSCIENCE, INC.

2015 Q4 Form 10-Q Financial Statement

#000112170215000043 Filed on November 12, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q4
Revenue $496.0K $327.0K $856.0K
YoY Change -42.06% -48.26% 14.75%
Cost Of Revenue $347.0K $110.0K
YoY Change -55.85% -83.33%
Gross Profit -$20.00K $750.0K
YoY Change -87.01% 837.5%
Gross Profit Margin -6.12% 87.62%
Selling, General & Admin $1.640M $1.769M $2.540M
YoY Change -35.43% -28.44% -26.16%
% of Gross Profit 338.67%
Research & Development $1.570M $1.660M $4.060M
YoY Change -61.33% -59.41% -11.74%
% of Gross Profit 541.33%
Depreciation & Amortization $100.0K $70.00K $80.00K
YoY Change 25.0% -30.0% -57.89%
% of Gross Profit 10.67%
Operating Expenses $3.200M $1.769M $6.600M
YoY Change -51.52% -28.44% -18.01%
Operating Profit -$5.917M -$3.106M -$5.807M
YoY Change 1.89% -53.7% -27.11%
Interest Expense $1.000K
YoY Change -75.0%
% of Operating Profit
Other Income/Expense, Net -$20.00K $1.000K $50.00K
YoY Change -140.0% -83.33% -600.0%
Pretax Income -$3.120M -$3.105M -$5.810M
YoY Change -46.3% -53.73% -27.1%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.917M -$5.848M -$6.252M
YoY Change -5.36% -25.91% -27.56%
Net Earnings / Revenue -1192.94% -1788.38% -730.37%
Basic Earnings Per Share
Diluted Earnings Per Share -$84.57M -$83.57M -$125.0M
COMMON SHARES
Basic Shares Outstanding 27.33M shares 26.98M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.30M $17.90M $20.00M
YoY Change -38.5% -29.8% 4.17%
Cash & Equivalents $12.27M $17.89M $20.05M
Short-Term Investments
Other Short-Term Assets $2.200M $1.400M $800.0K
YoY Change 175.0% 75.0% -72.41%
Inventory $51.00K $375.0K $586.0K
Prepaid Expenses
Receivables $238.0K $276.0K $45.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.85M $20.42M $21.97M
YoY Change -32.39% -26.0% -12.94%
LONG-TERM ASSETS
Property, Plant & Equipment $105.0K $908.0K $456.0K
YoY Change -76.97% 81.6% -42.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $95.00K $170.0K $95.00K
YoY Change 0.0% -75.71% 0.0%
Total Long-Term Assets $2.238M $1.697M $1.170M
YoY Change 91.28% 41.42% -22.36%
TOTAL ASSETS
Total Short-Term Assets $14.85M $20.42M $21.97M
Total Long-Term Assets $2.238M $1.697M $1.170M
Total Assets $17.09M $22.12M $23.14M
YoY Change -26.14% -23.19% -13.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $120.0K $448.0K $333.0K
YoY Change -63.96% 12.0% -42.49%
Accrued Expenses $3.513M $3.590M $3.709M
YoY Change -5.28% -0.28% -24.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.910M $4.192M $4.189M
YoY Change -6.66% -0.19% -32.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $150.0K $150.0K $150.0K
YoY Change 0.0% -25.0% 3.45%
Total Long-Term Liabilities $150.0K $150.0K $150.0K
YoY Change 0.0% -25.0% 3.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.910M $4.192M $4.189M
Total Long-Term Liabilities $150.0K $150.0K $150.0K
Total Liabilities $4.060M $4.342M $4.339M
YoY Change -6.43% -1.32% -31.56%
SHAREHOLDERS EQUITY
Retained Earnings -$325.8M -$319.8M -$302.1M
YoY Change 7.84% 10.84%
Common Stock $338.9M $337.7M $320.9M
YoY Change 5.58% 9.53%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.03M $17.78M $18.80M
YoY Change
Total Liabilities & Shareholders Equity $17.09M $22.12M $23.14M
YoY Change -26.14% -23.19% -13.48%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q4
OPERATING ACTIVITIES
Net Income -$5.917M -$5.848M -$6.252M
YoY Change -5.36% -25.91% -27.56%
Depreciation, Depletion And Amortization $100.0K $70.00K $80.00K
YoY Change 25.0% -30.0% -57.89%
Cash From Operating Activities -$5.470M -$4.260M -$5.900M
YoY Change -7.29% -11.06% -8.39%
INVESTING ACTIVITIES
Capital Expenditures -$150.0K -$290.0K -$20.00K
YoY Change 650.0% 480.0% -77.78%
Acquisitions
YoY Change
Other Investing Activities $0.00 $40.00K $330.0K
YoY Change -100.0% -93.84%
Cash From Investing Activities -$150.0K -$250.0K $310.0K
YoY Change -148.39% 400.0% -94.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -300.0K 0.000
YoY Change -101.2%
NET CHANGE
Cash From Operating Activities -5.470M -4.260M -5.900M
Cash From Investing Activities -150.0K -250.0K 310.0K
Cash From Financing Activities 0.000 -300.0K 0.000
Net Change In Cash -5.620M -4.810M -5.590M
YoY Change 0.54% -123.97% 377.78%
FREE CASH FLOW
Cash From Operating Activities -$5.470M -$4.260M -$5.900M
Capital Expenditures -$150.0K -$290.0K -$20.00K
Free Cash Flow -$5.320M -$3.970M -$5.880M
YoY Change -9.52% -16.24% -7.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001121702
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27331435 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Entity Registrant Name
EntityRegistrantName
METABOLIX, INC.
CY2014Q4 mblx Accrued Commercial Manufacturing Current
AccruedCommercialManufacturingCurrent
77000 USD
CY2015Q3 mblx Accrued Commercial Manufacturing Current
AccruedCommercialManufacturingCurrent
303000 USD
mblx Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
332000 USD
mblx Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
291000 USD
CY2015Q2 mblx Class Of Warrant Or Right Expiration Term
ClassOfWarrantOrRightExpirationTerm
P4Y
CY2014Q3 mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
4088000 USD
mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
13280000 USD
CY2015Q3 mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
4088000 USD
mblx Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
12332000 USD
mblx Increase Decrease In Deferred Rent And Long Term Liabilities
IncreaseDecreaseInDeferredRentAndLongTermLiabilities
-50000 USD
mblx Increase Decrease In Deferred Rent And Long Term Liabilities
IncreaseDecreaseInDeferredRentAndLongTermLiabilities
0 USD
CY2014Q3 mblx License And Royalty Revenue
LicenseAndRoyaltyRevenue
127000 USD
mblx License And Royalty Revenue
LicenseAndRoyaltyRevenue
215000 USD
CY2015Q3 mblx License And Royalty Revenue
LicenseAndRoyaltyRevenue
173000 USD
mblx License And Royalty Revenue
LicenseAndRoyaltyRevenue
455000 USD
CY2014Q3 mblx Number Of Units Purchased
NumberOfUnitsPurchased
50000000 shares
mblx Period Over Which Capital Resources Are Not Sufficient To Fund Planned Operations
PeriodOverWhichCapitalResourcesAreNotSufficientToFundPlannedOperations
P12M
mblx Private Placement Issuance Costs Incurred During Noncashor Partial Noncash Transaction
PrivatePlacementIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction
0 USD
mblx Private Placement Issuance Costs Incurred During Noncashor Partial Noncash Transaction
PrivatePlacementIssuanceCostsIncurredDuringNoncashorPartialNoncashTransaction
75000 USD
CY2014Q3 mblx Proceeds From Issuance Of Private Placement Gross
ProceedsFromIssuanceOfPrivatePlacementGross
25000000 USD
CY2014Q3 mblx Unit Price
UnitPrice
0.50
CY2015Q2 mblx Unit Price
UnitPrice
0.125
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
333000 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
448000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
45000 USD
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
276000 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3709000 USD
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3590000 USD
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
564000 USD
CY2015Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
724000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-64000 USD
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-72000 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
320707000 USD
CY2015Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
337416000 USD
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9602391 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9650857 shares
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6059833 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3328216 shares
CY2014Q4 us-gaap Assets
Assets
23135000 USD
CY2015Q3 us-gaap Assets
Assets
22120000 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
21965000 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
20423000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
128000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7698000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25486000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20046000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17894000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-460000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 USD
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.98
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22530322 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26981214 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8333333 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22530322 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26981214 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
135500000 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22600000 shares
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
225000 USD
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
270000 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8002000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23423000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5851000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17771000 USD
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
786000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1372000 USD
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
347000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
521000 USD
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
7346000 USD
us-gaap Costs And Expenses
CostsAndExpenses
22921000 USD
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
6591000 USD
us-gaap Costs And Expenses
CostsAndExpenses
19939000 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
147000 USD
CY2015Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
154000 USD
CY2012 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
38885000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
430000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
167000 USD
CY2014Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-294000 USD
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
-1430000 USD
CY2015Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
0 USD
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
0 USD
CY2014Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
-0.13
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
-0.33
CY2015Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
0.00
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic And Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare
0.00
CY2014Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
112000 USD
CY2015Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
147000 USD
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.84
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.32
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.73
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-141000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-4000 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2621000 USD
CY2015Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2026000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
33000 USD
CY2014Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
891000 USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
891000 USD
CY2015Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-6708000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-20961000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5848000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-17764000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.71
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-2.99
CY2015Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.22
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.73
CY2014Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1185000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-2321000 USD
CY2015Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-211000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
48000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-769000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
231000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1355000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
18000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-364000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
7000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
49000 USD
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
35000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-191000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-9000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-254000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
687000 USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-34000 USD
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-132000 USD
CY2014Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
4000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
6000 USD
CY2015Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3000 USD
CY2014Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
584000 USD
CY2015Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
331000 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
586000 USD
CY2015Q3 us-gaap Inventory Net
InventoryNet
375000 USD
CY2014Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2000 USD
CY2015Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
38000 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
0 USD
CY2015Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
6000 USD
CY2014Q3 us-gaap Inventory Write Down
InventoryWriteDown
657000 USD
us-gaap Inventory Write Down
InventoryWriteDown
886000 USD
CY2015Q3 us-gaap Inventory Write Down
InventoryWriteDown
202000 USD
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-109000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-141000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-3000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7000 USD
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000 USD
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Inventory Write Down
InventoryWriteDown
202000 USD
CY2015Q3 us-gaap Investments And Cash
InvestmentsAndCash
17894000 USD
CY2014Q4 us-gaap Liabilities
Liabilities
4339000 USD
CY2015Q3 us-gaap Liabilities
Liabilities
4342000 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23135000 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22120000 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4189000 USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4192000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
17788000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-2152000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
25213000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
14703000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
11358000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-458000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18642000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16393000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18182000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-16393000 USD
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7893000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23282000 USD
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5848000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-17764000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16000 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
34000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
77000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6714000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-20977000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5882000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-17841000 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
447000 USD
CY2015Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
537000 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
95000 USD
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
170000 USD
CY2014Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-109000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-140000 USD
CY2015Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-3000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-7000 USD
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
153000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
498000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1508000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
150000 USD
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
150000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
10000 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
74000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
580000 USD
CY2014Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
87000 USD
CY2015Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
297000 USD
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
288000 USD
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
0 USD
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
305000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
18796000 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
17778000 USD
CY2015Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1667
CY2014Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
420000 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2015Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9381316 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7017749 shares
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26979598 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24234043 shares
CY2015Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
619000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash and cash equivalents. The Company has historically invested its cash equivalents in highly rated money market funds, corporate debt, federal agency notes and U.S. treasury notes. Investments, when purchased, are acquired in accordance with the Company&#8217;s investment policy which establishes a concentration limit per issuer. At </font><font style="font-family:inherit;font-size:10pt;">September&#160;30, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company&#8217;s cash equivalents are invested solely in money market funds.</font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company provides credit to customers in the normal course of business. The Company performs ongoing credit evaluations of its customers&#8217; financial condition and limits the amount of credit extended when deemed necessary.</font></div></div>
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
756000 USD
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1443000 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
619000 USD
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
50000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
24913000 USD
CY2015Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
14703000 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
24913000 USD
CY2014Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
24913000 USD
CY2015Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
14703 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
14703000 USD
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
0 USD
us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
40000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
13019000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
300000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
456000 USD
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
908000 USD
us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
35000 USD
CY2014Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
624000 USD
CY2015Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
79000 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-302072000 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-319836000 USD
CY2014Q3 us-gaap Revenue From Grants
RevenueFromGrants
390000 USD
us-gaap Revenue From Grants
RevenueFromGrants
1301000 USD
CY2015Q3 us-gaap Revenue From Grants
RevenueFromGrants
327000 USD
us-gaap Revenue From Grants
RevenueFromGrants
1249000 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
115000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
428000 USD
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
209000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
394000 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
632000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1944000 USD
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
709000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
2098000 USD
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2472000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8269000 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2156000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7086000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1912000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1483000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name View Source Status
0001121702-15-000043-index-headers.html Edgar Link pending
0001121702-15-000043-index.html Edgar Link pending
0001121702-15-000043.txt Edgar Link pending
0001121702-15-000043-xbrl.zip Edgar Link pending
ex-311x20150930.htm Edgar Link pending
ex-312x20150930.htm Edgar Link pending
ex-31x20150930.htm Edgar Link pending
ex-321x20150930.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mblx-20150930.xml Edgar Link completed
mblx-20150930.xsd Edgar Link pending
mblx-20150930x10q.htm Edgar Link pending
mblx-20150930_cal.xml Edgar Link unprocessable
mblx-20150930_def.xml Edgar Link unprocessable
mblx-20150930_lab.xml Edgar Link unprocessable
mblx-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending